These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3032052)

  • 1. Thrombin: active-site topography.
    Berliner LJ; Birktoft JJ; Miller TL; Musci G; Scheffler JE; Shen YY; Sugawara Y
    Ann N Y Acad Sci; 1986; 485():80-95. PubMed ID: 3032052
    [No Abstract]   [Full Text] [Related]  

  • 2. Active-site topography of human coagulant (alpha) and noncoagulant (beta) thrombins.
    Berliner LJ; Bauer RS; Chang TL; Fenton JW; Shen YY
    Biochemistry; 1981 Mar; 20(7):1831-7. PubMed ID: 6261806
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for multiple conformational changes in the active center of thrombin induced by complex formation with thrombomodulin: an analysis employing nitroxide spin-labels.
    Musci G; Berliner LJ; Esmon CT
    Biochemistry; 1988 Jan; 27(2):769-73. PubMed ID: 2831973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron spin resonance and fluorescence studies of the conformational environment of the thiol groups of thrombospondin: interactions with thrombin.
    Sankarapandi S; Walz DA; Zafar RS; Berliner LJ
    Biochemistry; 1995 Aug; 34(33):10491-6. PubMed ID: 7654703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific interaction of thrombin and inhibitors observed by fluorescence correlation spectroscopy.
    Klingler J; Friedrich T
    Biophys J; 1997 Oct; 73(4):2195-200. PubMed ID: 9336216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex formation of ulinastatin with alpha-thrombin].
    Mimura K; Shinozawa K; Kobayashi T; Fukutake K; Yatsuhashi T; Fukutake K
    Rinsho Byori; 1992 Sep; 40(9):987-92. PubMed ID: 1331576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 10. X-ray analysis of a thrombin inhibitor-trypsin complex.
    Matsuzaki T; Sasaki C; Okumura C; Umeyama H
    J Biochem; 1989 Jun; 105(6):949-52. PubMed ID: 2768221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predicted tertiary structure of a thrombin inhibitor-trypsin complex explains the mechanisms of the selective inhibition of thrombin, factor Xa, plasmin, and trypsin.
    Matsuzaki T; Sasaki C; Umeyama H
    J Biochem; 1988 Mar; 103(3):537-43. PubMed ID: 2968979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
    Mlinsek G; Novic M; Kotnik M; Solmajer T
    J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The thrombin receptor: "All that is mine I carry with me"].
    Medzhitov RM
    Biokhimiia; 1992 Nov; 57(11):1757-8. PubMed ID: 1336983
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombomodulin increases the rate of thrombin inhibition by BPTI.
    Rezaie AR; He X; Esmon CT
    Biochemistry; 1998 Jan; 37(2):693-9. PubMed ID: 9425093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of thrombin with thrombomodulin.
    Esmon CT; Esmon NL; Kurosawa S; Johnson AE
    Ann N Y Acad Sci; 1986; 485():215-20. PubMed ID: 3032042
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of dansylated peptidyl chloromethanes with trypsin, chymotrypsin, elastase, and thrombin.
    Penny GS; Dyckes DF
    Biochemistry; 1980 Jun; 19(13):2888-94. PubMed ID: 6901612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.
    Hung DT; Vu TK; Wheaton VI; Charo IF; Nelken NA; Esmon N; Esmon CT; Coughlin SR
    J Clin Invest; 1992 Feb; 89(2):444-50. PubMed ID: 1310695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.